News Article

Candesic examines the phenomenon of synthetic human embryos

23 October 2023

Dr Leonid Shapiro, Managing Partner at Candesic, and Dr Joe Taylor, principal at Candesic, examine the phenomenon of synthetic human embryos in the latest PharmaTimes Media Ltd. Developing clear and rigorous regulatory frameworks for synthetic human embryos will be crucial to the development of their potential uses.